372 related articles for article (PubMed ID: 31184554)
1. Dexamethasone intravitreal implant (OZURDEX
Massa H; Georgoudis P; Panos GD
Ther Deliv; 2019 Jun; 10(6):343-351. PubMed ID: 31184554
[TBL] [Abstract][Full Text] [Related]
2. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
[TBL] [Abstract][Full Text] [Related]
4. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
8. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
Kong X; Psaras C; Stewart JM
Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
[TBL] [Abstract][Full Text] [Related]
10. Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia.
Teja S; Sawatzky L; Wiens T; Maberley D; Ma P
Can J Ophthalmol; 2019 Oct; 54(5):540-547. PubMed ID: 31564342
[TBL] [Abstract][Full Text] [Related]
11. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
[TBL] [Abstract][Full Text] [Related]
13. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
[TBL] [Abstract][Full Text] [Related]
14. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
Brunner M; Haueter I; Valmaggia C
Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
[TBL] [Abstract][Full Text] [Related]
15. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis.
Tomkins-Netzer O; Taylor SR; Bar A; Lula A; Yaganti S; Talat L; Lightman S
Ophthalmology; 2014 Aug; 121(8):1649-54. PubMed ID: 24650556
[TBL] [Abstract][Full Text] [Related]
16. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
[TBL] [Abstract][Full Text] [Related]
18. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
19. Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex).
Garweg JG; Baglivo E; Freiberg FJ; Pfau M; Pfister IB; Michels S; Zandi S
J Ocul Pharmacol Ther; 2016 Sep; 32(7):442-50. PubMed ID: 27479780
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
Kim M; Kim SA; Park W; Kim RY; Park YH
Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]